Table 3

Mean (SD) changes from baseline to 30 minutes of nasal continuous positive airways pressure (NCPAP)

0 cm H2O 5 cm H2O 10 cm H2OANOVA (two- way interaction)
CI (l/min/m2)AF0.12  (0.22)−0.07  (0.22)−0.23  (0.13)
SR−0.05 (0.14)0.21 (0.25)0.23 (0.32)0.003
SBP (mm Hg)AF0 (4.1)1 (7.1)7.7 (9.2)
SR3 (3.9)0.6 (3.1)−2.6 (4.2)0.03
SVI (ml/m2)AF1.27 (5.36)−2.77 (4.91)−5.35 (3.65)
SR−0.60 (1.62)2.42 (2.85)3.94 (5.45)0.02
SVR (dyne.s/cm5)AF−66 (207)93 (306)253 (199)
SR144 (354)−134 (144)−246 (295)0.002
MAP (mm Hg)AF1.6 (2.8)2.3 (6.3)2.9 (7.6)
SR2.3 (4.9)0.9 (2.8)−2.3 (4.1)NS
MPAP (mm Hg)AF−0.5 (2.9)−1.8 (3.7)1.8 (2.8)
SR0.4 (2.1)2.4 (1.5)−0.8 (3.1)NS
PCWP (mm Hg)AF0.7 (2.3)1.3 (1.8)2.9 (4.9)
SR−0.4 (2.9)1.6 (1.5)1 (1.4)NS
PVR (dyne.s/cm5)AF−33.1 (35.7)−56.6 (63.8)0.9 (95.9)
SR37.4 (49.1)4.2 (24.6)−53.7 (91.6)NS
RAP (mm Hg)AF−0.2 (1.3)0.6 (1.0)2.7 (1.4)
SR0 (0.7)1.2 (0.8)1 (1.4)NS
  • Change from time 0 to 30 minutes of NCPAP application at each pressure, according to subgroup. AF = atrial fibrillation; SR = sinus rhythm; CI = cardiac index; SVI = stroke volume index; HR = heart rate; SBP = systolic blood pressure; MAP = mean blood pressure; PAP = mean pulmonary artery pressure; PCWP = pulmonary capillary wedge pressure; RAP = mean right atrial pressure; SVR = systemic vascular resistance; PVR = peripheral vascular resistance.